HSBC Holdings’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-93,256
Closed -$296K 3207
2020
Q3
$296K Sell
93,256
-5,378
-5% -$17.2K ﹤0.01% 2267
2020
Q2
$287K Buy
+98,634
New +$312K ﹤0.01% 2156
2020
Q1
Sell
-13,072
Closed -$43K 3183
2019
Q4
$43K Buy
13,072
+616
+5% +$1.79K ﹤0.01% 2978
2019
Q3
$27K Buy
+12,456
New +$33.3K ﹤0.01% 3034
2019
Q2
Sell
-10,175
Closed -$38K 2954
2019
Q1
$38K Buy
+10,175
New +$34.4K ﹤0.01% 2660
2017
Q2
Sell
-223,634
Closed -$520K 2364
2017
Q1
$520K Sell
223,634
-27,057
-11% -$59.9K ﹤0.01% 1597
2016
Q4
$531K Buy
250,691
+27,860
+13% +$77.7K ﹤0.01% 1784
2016
Q3
$745K Hold
222,831
﹤0.01% 1435
2016
Q2
$700K Buy
222,831
+1,716
+0.8% +$5.72K ﹤0.01% 1451
2016
Q1
$737K Buy
221,115
+553
+0.3% +$1.72K ﹤0.01% 1414
2015
Q4
$786K Sell
220,562
-4,016
-2% -$16.8K ﹤0.01% 1529
2015
Q3
$1.13M Sell
224,578
-168,154
-43% -$964K ﹤0.01% 1192
2015
Q2
$2.54M Buy
392,732
+99,956
+34% +$670K 0.01% 1011
2015
Q1
$2.06M Buy
+292,776
New +$2.12M ﹤0.01% 1171

Other funds holding PDLI